EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 111 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $301,427 | -55.6% | 88,655 | -4.1% | 0.00% | – |
Q2 2023 | $679,463 | -29.1% | 92,444 | 0.0% | 0.00% | – |
Q1 2023 | $957,720 | -54.7% | 92,444 | -48.4% | 0.00% | -100.0% |
Q4 2022 | $2,113,955 | -32.4% | 178,997 | +20.2% | 0.00% | -50.0% |
Q3 2022 | $3,127,000 | +1.8% | 148,954 | +50.5% | 0.00% | +100.0% |
Q2 2022 | $3,071,000 | -46.2% | 98,946 | -28.8% | 0.00% | -50.0% |
Q1 2022 | $5,705,000 | +33.4% | 138,950 | +41.2% | 0.00% | 0.0% |
Q4 2021 | $4,276,000 | -45.5% | 98,372 | -37.2% | 0.00% | -33.3% |
Q3 2021 | $7,839,000 | -9.9% | 156,555 | +13.4% | 0.00% | 0.0% |
Q2 2021 | $8,698,000 | -33.9% | 138,090 | -2.5% | 0.00% | -50.0% |
Q1 2021 | $13,161,000 | +4.0% | 141,650 | +0.3% | 0.01% | 0.0% |
Q4 2020 | $12,654,000 | -14.1% | 141,226 | -0.9% | 0.01% | -25.0% |
Q3 2020 | $14,723,000 | +52.7% | 142,490 | +16.9% | 0.01% | +33.3% |
Q2 2020 | $9,639,000 | +48.8% | 121,893 | +8.8% | 0.01% | +20.0% |
Q1 2020 | $6,480,000 | +1.3% | 112,003 | -5.5% | 0.01% | +25.0% |
Q4 2019 | $6,394,000 | +3.4% | 118,521 | +0.2% | 0.00% | 0.0% |
Q3 2019 | $6,186,000 | -2.5% | 118,321 | -9.9% | 0.00% | 0.0% |
Q2 2019 | $6,342,000 | +11.2% | 131,271 | +16.3% | 0.00% | 0.0% |
Q1 2019 | $5,702,000 | -11.4% | 112,871 | +4.0% | 0.00% | -20.0% |
Q4 2018 | $6,434,000 | -22.9% | 108,532 | -14.4% | 0.01% | 0.0% |
Q3 2018 | $8,346,000 | +57.6% | 126,780 | +20.9% | 0.01% | +25.0% |
Q2 2018 | $5,295,000 | +15.0% | 104,872 | +19.9% | 0.00% | +33.3% |
Q1 2018 | $4,605,000 | +13.3% | 87,472 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $4,065,000 | +8.8% | 87,472 | -5.3% | 0.00% | 0.0% |
Q3 2017 | $3,736,000 | +16.2% | 92,372 | -2.6% | 0.00% | +50.0% |
Q2 2017 | $3,214,000 | +123.5% | 94,792 | +91.5% | 0.00% | +100.0% |
Q1 2017 | $1,438,000 | -11.6% | 49,512 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $1,626,000 | +4.2% | 49,512 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $1,561,000 | -11.6% | 49,512 | -21.2% | 0.00% | -50.0% |
Q2 2016 | $1,766,000 | -11.9% | 62,812 | +13.9% | 0.00% | 0.0% |
Q1 2016 | $2,005,000 | +11.3% | 55,152 | +22.4% | 0.00% | 0.0% |
Q4 2015 | $1,802,000 | +41.1% | 45,042 | +0.5% | 0.00% | +100.0% |
Q3 2015 | $1,277,000 | -13.7% | 44,812 | -0.2% | 0.00% | 0.0% |
Q2 2015 | $1,479,000 | +21.9% | 44,882 | +6.4% | 0.00% | 0.0% |
Q1 2015 | $1,213,000 | +0.3% | 42,182 | -5.0% | 0.00% | 0.0% |
Q4 2014 | $1,209,000 | +27.8% | 44,382 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $946,000 | -5.1% | 44,382 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $997,000 | -11.1% | 44,382 | -0.0% | 0.00% | 0.0% |
Q1 2014 | $1,122,000 | +2.4% | 44,392 | -6.9% | 0.00% | 0.0% |
Q4 2013 | $1,096,000 | +20.7% | 47,672 | +0.1% | 0.00% | 0.0% |
Q3 2013 | $908,000 | +30.6% | 47,638 | -1.2% | 0.00% | 0.0% |
Q2 2013 | $695,000 | – | 48,199 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |